We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Otsuka Sues FDA Over Alleged End-Run Around Abilify Exclusivity
Otsuka Sues FDA Over Alleged End-Run Around Abilify Exclusivity
Otsuka is suing to block the FDA from allowing generic versions of its blockbuster antipsychotic Abilify years before the drug’s orphan product exclusivity runs out.